Agoracom Blog Home

Posts Tagged ‘weed’

« Older Entries
Newer Entries »

Spyder #Cannabis $SPDR.ca – DOPE! New cannabis compound 30 TIMES more potent than #THC found in one #marijuana variety $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 1:00 PM on Monday, January 13th, 2020

SPONSOR: Spyder Cannabis (SPDR:TSXV) An established chain of high-end vape stores. Aggressive expansion plan is already in place that will focus on Canadian retail and US Hemp derived kiosks in high traffic areas. Click here for more info.

DOPE! New cannabis compound 30 TIMES more potent than THC found in one marijuana variety

  • Compound is one of two newfound cannabinoids that have been discovered in the Cannabis plant glands of the sativa L species.

By: Charlotte Edwards

A NEW cannabis compound has been discovered and it may be 30 times more potent than THC.

Scientists aren’t yet sure whether the compound causes a high or has medical benefits so they’ve been conducting tests to try and figure this out.

The compound is one of two newfound cannabinoids that have been discovered in the Cannabis plant glands of the sativa L species.

Cannabinoids is the collective term for the group of diverse chemical compounds that act on the cannabinoid receptors of the brain.

THC is just one of these cannabinoids and it’s currently considered to be the principal psychoactive component of cannabis.

THC, or tetrahydrocannabinol, plugs into brain receptors and can alter our ability to co-ordinate movements, reason, record memories and perceive things like time and pleasure.

  THC in cannabis is what can give smokers a high feelingCredit: Getty – Contributor

It’s thought that cannabis contains over 140 similar chemicals that can interact with receptors all over the body.

However, THC is currently the only one we know can result in a high spaced out feeling.

Of the two new cannabinoids discovered, one looks similar to the compound CBD, which isn’t psychoactive.

The other appears similar to THC but may even produce stronger mind-bending effects.

This THC lookalike is called tetrahydrocannabiphorol (THCP).

Recent research suggests that it interacts with the same brain receptor as THC but has slight differences in its chain of atoms.

The slight difference in shape of THCP means it can technically fit more snugly into its preferred brain receptor than THC.

A test showed that the compound can actually bind 30 times more reliably than THC.

When given to lab mice, the THCP made them behave as if they were on THC with slower movements and decreased reactions to pain.

The mice reached this state with a much lower does than would have been required with THC meaning the new compound is stronger.

However, this lab experiment still doesn’t mean that the same effect would happen in humans.

THCP doesn’t appear to be present in large amounts in cannabis plants but even if it was, increased psychoactive properties would still not be guaranteed.

Source: https://www.thesun.co.uk/tech/10725348/new-cannabis-compound-more-potent-weed/

Tags: , , , , , , , ,
Posted in All Recent Posts, Spyder Cannabis Inc. | Comments Off on Spyder #Cannabis $SPDR.ca – DOPE! New cannabis compound 30 TIMES more potent than #THC found in one #marijuana variety $CGC $ACB $APH $CRON.ca $OGI.ca

PRIMO Nutraceuticals Inc. $PRMO.ca – 2020 could be a defining year for the #cannabis industry #CBD $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 9:00 PM on Sunday, January 12th, 2020

SPONSOR:  PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) provides strategic capital to the thriving cannabis cultivation sector through ownership and development of commercial real estate properties. The company also offers fully built out turnkey facilities equipped with state-of-the-art growing infrastructure to cannabis growers and processors. Click here for more info.

2020 could be a defining year for the cannabis industry

  • “There’s going to be a lot of movement in 2020,” said Chris Walsh, chief executive officer of Marijuana Business Daily, a cannabis industry trade publication. “Whether it leads to actual legalization in some states remains to be seen.”

By Alicia Wallace, CNN Business

New York (CNN Business)2019 was a momentous year for the cannabis industry: Hemp-derived CBD had a heyday, Illinois made history, California got sticky, vapes were flung into flux, and North American cannabis companies received some harsh wake-up calls. 2020 is gearing up to be an even more critical year.   There’s a well-worn saying in the cannabis business that the emerging industry is so fast-moving that it lives in dog years. 2020 is barely a week old, and cannabis is already making headlines after Illinois kicked off the new year with recreational sales. Other states are inching closer to legalization this year — with several mulling how best to ensure social equity. Also in 2020, there’s the FDA could chill the CBD craze, and a move from Congress could change the game entirely. The tumultuous past few months have set 2020 up to be a make-or-break year for some of the biggest in the business as well as the scores of lesser-known players priming to make their moves.   “There’s going to be a lot of movement in 2020,” said Chris Walsh, chief executive officer of Marijuana Business Daily, a cannabis industry trade publication. “Whether it leads to actual legalization in some states remains to be seen.”

The next US states to legalize cannabis

Fourteen US states and territories have legalized recreational cannabis sales for adults (although regulations aren’t fully fleshed out in places like the District of Columbia and Vermont). A total of 33 states have legalized cannabis for medical purposes. Illinois will remain in focus, after it made history last year with the first legislatively-enacted recreational cannabis program. Critical aspects of its program include social equity and social justice measures created to help people and communities most harmed by the War on Drugs.   “Underserved groups are holding the industry accountable,” said Gia Morón, executive vice president for Women Grow, a company founded to further the presence of women in the cannabis industry. “And our legislators are recognizing that [social, gender and minority concerns] are a part of this now.”   New York and New Jersey have been flirting with legalization but have held off to navigate some logistics related to aspects that include social equity. The governors of New York, New Jersey, Connecticut and Pennsylvania convened this past fall for a summit on coordinating cannabis and vaping policies. New Jersey is putting a recreational cannabis measure before voters in November, and Gov. Andrew Cuomo vowed Wednesday that New York would legalize cannabis this year. Other possibilities for states to legalize recreational cannabis could be Arizona, Delaware, Florida, Minnesota, Montana, New Mexico, North Dakota and South Dakota, Walsh said. Even Alabama, Mississippi and South Dakota could become new medical cannabis markets and other states’ medical programs could see expansions, he added.   “If you look at the map right now of the US, we’re getting to the point where there isn’t that many [states] left that can legalize,” he said. “You can look at any of those and say there might be a chance in the next year or two for them to legalize.”

Federal legalization

Whether national legalization is on the horizon remains to be seen, said Walsh. How federal agencies regulate hemp, a cannabis plant with under 0.3% tetrahydrocannabinol (THC), and derivatives such as cannabidiol (CBD) could be extremely telling for how the US government might approach regulation of other forms of cannabis down the road, he said. CBD products have been all the rage, but they may be on shaky ground. CBD oils, creams, foods and beverages have seen an explosion in availability following the passage of the 2018 Farm Bill, which legalized hemp but left plenty of discretion to the US Food and Drug Administration, which regulates pharmaceutical drugs, most food items, additives and dietary supplements. The FDA is reviewing CBD and has yet to issue formal guidance, although the agency has issued warning letters to CBD makers that make unsubstantiated health claims. Class action lawsuits have been filed against several CBD companies, including two of the largest, Charlotte’s Web and CV Sciences, alleging they engaged in misleading or deceptive marketing practices, Stat News reported.   Cannabis insiders are closely awaiting the fate of industry-friendly bills such as the STATES Act, which would recognize cannabis programs at the state level, and the SAFE Banking Act, which would allow for banks to more easily serve cannabis companies. Those and other bills likely won’t pass in full, but it’s possible that some language makes it into more comprehensive legislation, Walsh said.   “It feels like [legalization] has to happen soon, but it might not happen how people think. You get a bill passed to allow banks to clearly serve this industry without a whole bunch of restrictions, and that could be pseudo-legalization,” Walsh said. “So, the actual move by the federal government to ‘legalize’ marijuana or let states decide might not come for years; but that reality might play out anyway with some other type of legislation.”

New regulation in older markets

In addition to the promise of new markets, the evolution of established cannabis programs could also play a significant role in the cannabis business landscape. In California, the world’s largest cannabis industry has developed in fits and starts. Regulators are taking aim at an entrenched illicit market as businesses decry tax increases and local control measures that limit distribution.   “California is going to get worse before it gets better,” Walsh said. And in Colorado, where the nation’s first legal recreational cannabis sale took place, a slate of new laws are poised to shift the cannabis landscape by allowing for social consumption businesses and the ability for out-of-state and publicly traded companies to own licenses.

New products come to Canada

Canada’s “Cannabis 2.0” roll-out of derivative products — such as edibles, vapes and beverages — is in its beginning stages. The Canadian publicly traded licensed producers that have been beset by missed and slow market development have bet heavily on these new product forms.     But it takes time for provincial and state cannabis programs to get off the ground, for businesses to come online and for production and supply to get in a good balance with demand. So any big returns won’t happen immediately, said Morgan Paxhia, managing director and co-founder of cannabis investment firm Poseidon Asset Management. “It’s not going to look any better in Q1 and really into Q2,” he said of the Canadian cannabis sector.

‘Blockbuster failures’

Overall, 2020 should bring volatility for cannabis companies in Canada and the United States, he said, noting the industry’s current business cycle is mirroring that of the dot-com bubble and subsequent burst.   “There were very good companies that have emerged from that period, but most of the companies during that time are gone,” he said. Paxhia expects at least one — if not several — “blockbuster failures.”   The capital constraints are expected to continue into the first leg of 2020 as some initial bets don’t pan out for some companies, said Andrew Freedman, Colorado’s former cannabis czar who now runs Freedman & Koski, a firm that consults with municipalities and states navigating legalization. Some companies’ low points could create opportunities for other firms and investors that waited out the first cycle, Freedman said.   “In 2020, I see that everybody will understand the economics of cannabis a little bit better,” he said.   Source: https://edition.cnn.com/2020/01/09/business/cannabis-2020-legalization/index.html

Tags: , , , , , ,
Posted in All Recent Posts | Comments Off on PRIMO Nutraceuticals Inc. $PRMO.ca – 2020 could be a defining year for the #cannabis industry #CBD $CROP.ca $VP.ca NF.ca $MCOA

Spyder #Cannabis $SPDR.ca – Exploring Canada’s Cannabis Demand-Supply Landscape $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 4:48 PM on Thursday, January 9th, 2020

SPONSOR: Spyder Cannabis (SPDR:TSXV) An established chain of high-end vape stores. Aggressive expansion plan is already in place that will focus on Canadian retail and US Hemp derived kiosks in high traffic areas. Click here for more info.

Exploring Canada’s Cannabis Demand-Supply Landscape

By Sushree Mohanty

  • Cannabis demand is rising
  • However, there seems to be a gap between cannabis demand and supply in Canada
  • It’s been a year since Canada legalized marijuana, but it seems consumers in the country are still struggling to obtain legal cannabis
  • This demand-supply imbalance took a toll on cannabis companies’ revenues and stock prices last year

Let’s take a closer look at the demand-supply imbalance in Canada.

The cannabis demand-supply landscape in Canada

Health Canada has come up with a national Cannabis Tracking System to keep track of the cannabis produced and sold across the country. The intention is to keep a check on illegal cannabis sales. Health Canada requires federal license holders and provincial and territorial growers to report this data on a monthly basis.

Another objective behind this move could be to ensure that cannabis producers aren’t growing marijuana illegally. Such was the case last year with CannTrust (NYSE:CTST). The company was found to be growing marijuana illegally and was reportedly in violation of Health Canada’s regulations.

The monthly report tracks the sales of medical and recreational marijuana. It also takes into account the cannabis inventories held by retailers and distributors. Here are a few details from the report for the period that ended on September 30, 2019:

  • Total sales of dried cannabis fell by 0.4% to 12,922 kilograms on a month-to-month basis.
  • Cannabis oil total sales rose by 4.8% to 11,187 liters on a month-to-month basis.
  • The total amount of finished dried cannabis inventory rose by 5% to 64,151 kilograms on a month-to-month basis.
  • The total amount of finished cannabis oil inventory rose by 1.1% to 102,060 liters on a month-to-month basis.

“Finished inventory” here implies that the products are ready and packed for sale. The finished inventory for dried cannabis was higher for both provincial and territorial distributors and retailers and federal license holders.

For dried cannabis, federal license holders saw a 5.7% increase in finished inventories, while provincial and territorial distributors and retailers saw a 4.3% increase. Additionally, for cannabis oil, federal license holders saw a 2.6% increase in inventories, while provincial and territorial distributors and retailers saw a 1.4% decrease.

What caused the imbalance?

Canada legalized marijuana in October 2018. The demand for marijuana was high in the country. Thus, producers cultivated more cannabis, hoping to meet this demand. However, regulatory procedures were slow and strenuous, which resulted in a delay in the licensing and opening of new legal stores. The delay resulted in higher inventories and caused supply issues. Hence, cannabis sales were affected across Canada. Looking at the data for September, we can conclude that most retailers had products ready for sale. However, the lack of stores caused a supply issue and a rise in inventory.

Moreover, the licensing process isn’t that simple. A Cannabiz Media article stated, “The amount of time to obtain a license to grow marijuana in Canada’s legal market was excessive with some cultivators waiting months or even a year. Once a grower obtained a cultivation license, it needed to produce two full crops, have them tested, get its sales software audited, and apply for a sales license, which could take another year.”

How’s the marijuana demand and supply situation in the US?

While we’re on the subject, let’s talk about the demand and supply situation in the US. Marijuana isn’t legal at the federal level in the US. However, 33 states and the District of Columbia allow medical marijuana. Additionally, 11 states and the District of Columbia allow recreational marijuana.

Black market sales are a matter of concern even in the US. California, which legalized medical marijuana in 1996 and adult-use marijuana in 2016, also suffers from illicit cannabis activity. An article by Cannabis Business Plan discussed how cannabis consumers in the state will initially be inclined toward the illegal market to avoid regulatory costs. The article also stated that predictions show that by 2022, the marijuana market in the state could be worth $7.7 billion driven mostly by recreational marijuana.

Cannabiz Media also discussed how states such as Michigan are facing supply shortages due to a lack of licensed growers. Recently, recreational marijuana sales went live in Michigan. Pennsylvania faced similar problems when demand for medical cannabis couldn’t match supply in the state.

Furthermore, the abundance of marijuana resulted in losses for many licensed cultivators as prices fell. Obtaining capital for cannabis businesses is still an issue in the US. Banks and financial institutions are scared to provide help to cannabis companies because marijuana is still illegal federally. However, hopes are that the passing of the SAFE Act could smooth this process.

How are cannabis companies coping with the demand-supply situation?

The demand-supply imbalance hit cannabis companies’ revenues and profitabilities last year. After Canada legalized cannabis, companies increased their production capacities to match demand. However, the lack of legal stores caused a supply issue. Initially, Ontario was strict with its cannabis laws. Recently, though, after the second phase of legalization, Ontario relaxed its laws to tackle the problem of black market sales. Canada’s three largest provinces now expect higher sales this year from the Cannabis 2.0 expansion.

Hence, Aurora Cannabis (NYSE:ACB), Canopy Growth (TSE:WEED), Cronos Group (NASDAQ:CRON), and HEXO (TSE:HEXO) have struggled with overproduction. The companies missed their revenue targets and reported lower profitabilities in 2019. HEXO even withdrew its fiscal 2020 outlook due to lower store rollout issues.

Cannabis edibles are in high demand among marijuana products. Hence, consumers turned to the black market to obtain these products when Canada hadn’t legalized edibles. The prices of cannabis products on the black market are also lower than they are on the legal market. Now, with Cannabis 2.0 products ready to hit the stores, marijuana companies expect to recover their losses in 2020. These companies are ready with a variety of edibles, vapes, and beverages.

Though analysts expect a turnaround in 2020, they’ve kept a subdued outlook on marijuana companies’ 2020 revenues. Some analysts feel regulations and licensing delays could still affect Cannabis 2.0 revenues this year. Companies’ 2020 revenue estimates are as follows:

  • Aurora Cannabis’s fiscal 2020 revenue could be around 371.6 million Canadian dollars.
  • Canopy Growth’s (NYSE:CGC) fiscal 2020 revenue could be around 403.3 million Canadian dollars.
  • Cronos Group’s fiscal 2020 revenue could be around 146.1 million Canadian dollars.
  • HEXO’s fiscal 2020 revenue could be around 79.1 million Canadian dollars.

Final thoughts

The demand-supply imbalance in the cannabis market is an important issue. However, we also have to consider that the industry is a growing one and will have its ups and downs. Currently, the flow of regulations isn’t smooth, which is causing licensing and cultivation delays. It may take some time for things to smooth out in the industry.

Many also feel that federal legalization will help balance the demand-supply issue in the US. Nevertheless, considering the efforts by Canada and certain states in the US, we can expect a turnaround in 2020.

Stay tuned to learn more about the ins and outs of the marijuana industry.

Source: https://articles2.marketrealist.com/2020/01/exploring-canadas-cannabis-demand-supply-landscape/#

Tags: , , , , , , , ,
Posted in All Recent Posts, Spyder Cannabis Inc. | Comments Off on Spyder #Cannabis $SPDR.ca – Exploring Canada’s Cannabis Demand-Supply Landscape $CGC $ACB $APH $CRON.ca $OGI.ca

North Bud Farms $NBUD.ca Provides Corporate Update $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 4:16 PM on Thursday, January 9th, 2020
  • In late December completed first harvest at Salinas, California cultivation facility
  • Harvested 2,687 plants that were included in the acquisition of the Qlora Group

TORONTO, Jan. 09, 2020 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company“) is pleased to provide shareholders with the following corporate update:

Cannabis Production Facility in Salinas, California

In late December we completed our first harvest at our Salinas, California cultivation facility. We harvested 2,687 plants that were included in the acquisition of the Qlora Group (“Qlora”). The Company anticipates completing testing and sale of the product in late January 2020, which will represent the first revenue generated by the Company in California.  The Company has also completed an in-depth review and analysis of both the infrastructure and cultivation practices and will be implementing significant efficiencies over the course of the next four harvests. The Company anticipates continual harvests of 2,000-3,000 plants every 25 days, with quality and yield improving with each harvest. This product will be sold via wholesale agreements to existing Qlora clients in the interim as we prepare for the launch of NORTHBUD branded flower products in California in the third quarter of 2020.  

“Despite challenges faced by the cultivation team during this period of transition, we are extremely excited to be harvesting our first crops and look forward to continual improvements as we implement procedural and infrastructure efficiencies,” said Justin Braune, President of Bonfire Brands USA, a wholly owned subsidiary of NORTHBUD.

Cannabis Production Facility in Reno, Nevada

The Company is pleased to announce the completion of the first harvest of approximately 175 indoor grown plants. Upon the completion of testing and processing, the product will be distributed as NORTHBUD flower, pre-rolls and infused pre-rolls into selected Nevada dispensaries. The launching of NORTHBUD branded products into Nevada marks a significant milestone for the Company.

Status of Cultivation Licence Application for Cannabis Production Facility in Low, Quebec

On September 18, 2019, the Company received a confirmation of receipt of the site evidence package submitted in late August 2019. On November 22, 2019, the Company received a request for information from Health Canada (the “Request”).  The Request was received within the 60-business day service window for feedback provided by the regulator.  The Company is pleased to report that the Request was responded to in full in advance of the December 8th deadline. The Request did not contain any notices of deficiencies in the Company’s cultivation licence application nor did it require the Company to make any modifications or changes to its facility.

On December 19, 2019 the Company received a subsequent follow-up request for information consisting of two questions which were responded to that same day, and on December 20th, the Company received a request to clarify the roles of recently-hired employees in relation to the requested cultivation licence. This request was responded to in full on January 3, 2020. The Company has received no further communication from Health Canada.

The Company is confident that the approval process is on track and within comparable timelines experienced by other publicly-traded companies who have recently submitted evidence packages.  At this time, the Company cannot predict when it will be granted a cultivation licence by Health Canada. The Company will update shareholders on any further progress on the application.

Annual General Meeting

The Company wishes to inform shareholders that it will hold its Annual General and Special Meeting at 1:00 p.m. ET on Monday, February 3, 2020 at the office of McMillan LLP, World Exchange Plaza, Suite 2000, Ottawa, Ontario. The Company will file the required information for the annual and special meeting under its issuer profile on SEDAR at www.sedar.com.

Staffing and Personnel

The Company is pleased to announce the hiring of Adam Shapero as General Counsel. Adam comes to NORTHBUD after serving as Director of Risk Management, Corporate Secretary and Senior Counsel at Origin House (CSE: OH), who was recently acquired by Cresco Labs (CSE: CL) in a transaction valued at ~ $520 million. “We are extremely pleased to welcome Adam to our team,” said Sean Homuth, CEO of NORTHBUD. “His first-hand experience in the Cannabis industry will add tremendous value to our team while reducing our reliance on external counsel.”

About North Bud Farms Inc.

North Bud Farms Inc., through its wholly owned subsidiary GrowPros MMP Inc., is pursuing a license under The Cannabis Act.  The Company has built a state-of-the-art purpose-built cannabis production facility located on 135 acres of Agricultural Land in Low, Quebec, Canada. NORTHBUD through its wholly owned U.S. subsidiary, Bonfire Brands USA has acquired cannabis production facilities in California and Nevada. The Salinas, California property is located on 11 acres which currently consists of a 300,000 sq. ft. of licensable greenhouse space with 60,000 sq. ft. actively cultivating cannabis and a 2,000 sq. ft. building licensed for distribution.  The Reno, Nevada property is located on 3.2 acres of land which was acquired through the acquisition of Nevada Botanical Science, Inc. a world class cannabis production, research and development facility with 5,000 sq. ft. of indoor cultivation which holds medical and adult use licenses for cultivation, extraction and distribution.

For more information visit: www.northbud.com

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements and information included in this press release that, to the extent they are not historical fact, constitute forward-looking information or statements (collectively, “forward-looking statements”) within the meaning of applicable securities legislation.  Forward-looking statements, including, but not limited to, those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management.

Forward-looking statements, including, but not limited to, those regarding the success of the Company’s licence application in Quebec, future sales of cannabis in California and Nevada, plant harvest yields at the Company’s California and Nevada operations, conditions in the cannabis market, the Company entering agreements in connection with the B2B supply of cannabis and the Company’s transition into a revenue generating operational phase of development are based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements.  Such risks and uncertainties include, among others, the risk factors included in the Company’s final long form prospectus dated August 21, 2018, which is available under the Company’s SEDAR profile at www.sedar.com. Accordingly, readers should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statements to reflect information, events, results, circumstances or otherwise after the date hereof or to reflect the occurrence of unanticipated events, except as required by law including securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]

Tags: , , , , , , , ,
Posted in North Bud Farms Inc | Comments Off on North Bud Farms $NBUD.ca Provides Corporate Update $CGC $ACB $APH $CRON.ca $OGI.ca

NORTHBUD $NBUD.ca – When #CBD met chocolate $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 11:00 AM on Thursday, January 9th, 2020

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

When CBD met chocolate

The health-conscious, environmentally-aware consumer has encouraged new trends in the chocolate sector that affect flavour, texture and harvesting. Greater Goods has gone one step further, infusing the beloved food of the gods with CBD. Bethan Grylls hears from its co-founder about why this combination works.

Indulgent, premium and good-for-you: these words will be familiar to the modern-day confectioner as they look to address current trends1 and differentiate themselves in a competitive market. Be it a new sensory experience across taste, texture or colour; the lure of single-origin sourcing; or a guilt-free treat, the realms of chocolate innovation and buyer demands have stretched well beyond the days of penny sweets.

Some brands have taken things one step further, combining trends like organic, fair trade and non-GMO confectionery, with the demand for CBD – a term that was Googled 6. 4 million times during April 2019.2

Greater Goods, based in Oregon, US, is one example, offering its customers a selection of cannabinoid-infused ‘goodies’. Despite being a modest husband and wife venture, the team says they are looking to compete against the larger companies through hand-crafted, fun and unusually-flavoured products.

Source: https://www.newfoodmagazine.com/article/101342/when-cbd-met-chocolate/

Tags: , , , , , , , ,
Posted in North Bud Farms Inc | Comments Off on NORTHBUD $NBUD.ca – When #CBD met chocolate $CGC $ACB $APH $CRON.ca $OGI.ca

NORTHBUD $NBUD.ca – Canadians Bought 100 Tonnes Of Legal #Cannabis In First Year $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 10:45 AM on Wednesday, January 8th, 2020

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

Canadians Bought 100 Tonnes Of Legal Cannabis In First Year

  • Canadians bought nearly 100 tonnes of legal recreational cannabis in its first year of availability, according to new figures released by Health Canada.

Health Canada said 88,676 kilograms of dried flower cannabis was sold in Canada in the first year of legalization, according to its Cannabis Tracking System. Overall sales of legal dried cannabis by weight have nearly tripled since October 2018.

Statistics Canada said Tuesday that Canadian household spending on cannabis totaled $1.27 billion in the third quarter of 2019, with the illicit market accounting for $860 million of that figure and the legal market estimated at $417 million.

While 100 tonnes may sound like a lot, the amount sold through legal channels was far below what analysts projected Canadian demand would be, a sign that the illicit market continues to weigh on legal sales. CIBC World Markets said in mid-2018 that the Canadian market would demand about 400,000 kilograms of legal pot annually, while the Bank of Nova Scotia forecast total cannabis demand in Canada will be 900,000 kilograms this year.

Health Canada also said that the total active cultivation area for cannabis in the country reached 1.78 million square metres at the end of September, a sizable jump from the 452,896 square meters of cultivation that was licensed for legal pot a year earlier. Nearly five million cannabis plants were being grown by producers at the end of the first year of legalization, Health Canada said.

Source: https://menafn.com/1099515194/Canadians-Bought-100-Tonnes-Of-Legal-Cannabis-In-First-Year

Tags: , , , , , , , ,
Posted in North Bud Farms Inc | Comments Off on NORTHBUD $NBUD.ca – Canadians Bought 100 Tonnes Of Legal #Cannabis In First Year $CGC $ACB $APH $CRON.ca $OGI.ca

Spyder #Cannabis $SPDR.ca – More Canadians passing on beer in year one of legalization $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 5:00 PM on Tuesday, January 7th, 2020

SPONSOR: Spyder Cannabis (SPDR:TSXV) An established chain of high-end vape stores. Aggressive expansion plan is already in place that will focus on Canadian retail and US Hemp derived kiosks in high traffic areas. Click here for more info.

More Canadians passing on beer in year one of legalization

The report cites data from industry advocacy group Beer Canada, which found beer volumes fell by three per cent through November. Declining sales have led to several partnerships between alcohol and cannabis companies, such as Constellation Brands Inc.’s investment in Canopy Growth Corp. in November 2018. The recent decline in volumes is “far worse” than trends seen in the previous four years, when beer industry volumes fell an average of 0.3 per cent, according to Cowen & Co. analyst Vivien Azer.

Source: http://links.mkt2011.com/servlet/MailView?ms=MzA4MjU2MzMS1&r=MjU5OTkyNTIyMjg1S0&j=MTYyMzQzMjQyOAS2&mt=1&rt=0

Tags: , , , , , , , ,
Posted in Spyder Cannabis Inc. | Comments Off on Spyder #Cannabis $SPDR.ca – More Canadians passing on beer in year one of legalization $CGC $ACB $APH $CRON.ca $OGI.ca

NORTHBUD $NBUD.ca – Teas and edibles and vapes, oh my! $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 9:21 AM on Monday, January 6th, 2020

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

Teas and edibles and vapes, oh my!

By: Kyle Mack

The latest in cannabis products will be available for legal sale in Ontario.

The Ontario Cannabis Store (OCS) is releasing 59 new products including edibles, beverages, lotions, and concentrates in stores today but online Jan 16.

Prices of edibles range from $7.50 to $16 per item while beverages can cost between $4 to $10 and vapes falling between $25 – $125. Daniel Safayeni, Director of Policy at The Ontario Chamber of Commerce has previously released a statement on the THC limit per edible stating,

“The OCC supports a THC limit of 10-milligrams per discrete unit of edibles, as well as the sale of multi-packs or multiple products—up to a maximum of 100-milligrams of THC per package—within child-proof packaging. As we outline in the report, single-packs are costly, while multi-packs would allow licensed producers to create economies of scale. The proposed regulations, however, limit the amount of THC per package to only 10 milligrams, which is significantly lower than illegal alternatives and lower in other U.S. jurisdictions where recreational cannabis is legal”.

The THC cap may act as a barrier to shifting cannabis shoppers from making illicit purchases, where higher THC contents can be found.

For more information on edibles, visit the Ontario Cannabis Store.

Source: https://www.bttoronto.ca/2020/01/06/teas-and-edibles-and-vapes-oh-my/

Tags: , , , , , , , ,
Posted in North Bud Farms Inc | Comments Off on NORTHBUD $NBUD.ca – Teas and edibles and vapes, oh my! $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

NORTHBUD $NBUD.ca – Edibles, vapes and tea coming to legal Ontario cannabis shops Monday $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 2:38 PM on Friday, January 3rd, 2020

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. Learn More.

Edibles, vapes and tea coming to legal Ontario cannabis shops Monday

  • Ontario’s cannabis distributor says dozens of new marijuana products will be available in retail shops starting Monday but supplies will be limited.
  • Unveiled 59 new items today including a variety of vapes, edibles and a tea.

TORONTO – Ontario’s cannabis distributor says dozens of new marijuana products will be available in retail shops starting Monday but supplies will be limited.

The Ontario Cannabis Store unveiled 59 new items today including a variety of vapes, edibles and a tea.

The products will be available in the province’s legal cannabis retail stores starting next week and Cannabis edibles to hit store shelves in January.

The distributor estimates that products will be in short supply until March as manufacturers ramp up production to meet demand.

The number of products will grow to 100 in the coming months as they receive regulatory approval.

The OCS says the new selection will help it combat black market sales across the province.

Source: https://globalnews.ca/news/6362213/ontario-cannabis-store-edibles-vapes-tea-retail-shops/

Tags: , , , , , , , ,
Posted in North Bud Farms Inc | Comments Off on NORTHBUD $NBUD.ca – Edibles, vapes and tea coming to legal Ontario cannabis shops Monday $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Empower Clinics $CBDT.ca – Expert Offers Predictions For The Hemp-Derived #CBD Market in 2020 $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

Posted by AGORACOM-JC at 4:41 PM on Tuesday, December 31st, 2019

SPONSOR:

Why Empower Clinics

  • A leading owner/operator of physician staffed health and pain management clinics.
  • Patient database of over 165,000 patients 
  • Platform generating $1.4M USD (9 months ending Sept. 30, 2019)
  • Proprietary technology platforms including Electronic Health Records portal and e-Commerce for CBD product distribution
  • Recently launched CBD extraction facility
  • First extraction system capacity = 6,000 Kg per year.
  • CBD based products are poised to be a $20B global industry by 2022
  • Medical cannabis is poised to be a $100B global industry by 2025

Expert Offers Predictions For The Hemp-Derived CBD Market in 2020

By: Iris Dorbian

It was exactly a year ago that the Farm Bill legalized CBD and hemp, the latter a cousin to cannabis as it comes from the same plant. Of course, there were specified guidelines, such as hemp can be sold as long as the maximum THC (the psychoactive compound in cannabis that gives users their high) count is .3 percent; anything that contains more will be federally classified as illegal marijuana.

The legalization has spawned a booming cottage industry. But just like with the federally illegal cannabis market, problems proliferate for CBD and hemp entrepreneurs. For one thing, many vendors, retailers, advertisers, manufacturers and banks are still not fully apprised that hemp, for instance, is legal. Because of this misunderstanding, these prospective partners balk at working with hemp entrepreneurs, thinking they’ll be subject to the same penalties they would working with cannabis businesses.

CBD has not been immune to these setbacks, either. Despite its legality, the FDA has clamped down on businesses that sell CBD as food additives or label it as a dietary supplement. According to the food watchdog, CBD’s safety for use in human or animal food is inconclusive, requiring more data until proven otherwise.

In a press release, Patrick McCarthy, CEO and co-founder of ValidCare, a provider of market intelligence and research for the hemp-derived product industry, offered a few intriguing predictions for the space in 2020. Do you agree? Please let me know.

Safety Product Assurance

“Today’s consumer cares about where the products they put in, and on, their bodies come from. From big breweries to boutique ice creams, mainstream brands showcase their farmers in their advertising and market organic, cruelty-free and hyper-local manufacturing practices on their packaging to assure consumers their products are natural, safe and worth a premium price. This trend will hit the hemp industry next, as consumers demand information on plant origin, farming practices, product composition and sustainability.”

Baby Boomer Consumption Escalates

“The AARP crowd is one of the largest demographics using hemp-derived CBD for chronic joint pain and sleep. Expect this trend to increase as Boomers seek to replace prescription and OTC pharmaceuticals with hemp-derived products — and to lobby for coverage and/or reimbursement through FSAs, HSAs and supplemental MediCare policies.”

Hemp As Mental Health Aid

“Today, one in five Americans report they use hemp-derived CBD for ‘mental health reasons’ such as anxiety. In 2020, we’ll see even more people ditch Prozac prescriptions for non-impairing hemp-derived CBD to support their mental health goals. Expect brands targeting this audience to commission research on hemp-derived CBD’s functional benefits for mental health.”

Paving The Way For Minor Supplements

“CBD was this decade’s craze, but as the market for cannabidiol becomes oversaturated, product companies will introduce other interesting minor cannabinoids like CBN and CBG, already touted as having functional benefits tied to sleep and appetite. Expect the FDA to voice concerns about these ‘cannabis derived compounds’ and mirror its communication to industry and the public about the need for these products to be properly vetted for safety and use – and for product companies to market them nonetheless.”

Invasion of the Great White North

“Last year we witnessed a number of marijuana companies diversifying products and risks by introducing hemp-based wellness lines. In 2020, expect our Northern neighbors to take advantage of the depressed financial market and invest or buy U.S.-based hemp companies as a way to enter the U.S. market.”

Have a very happy and healthy New Year!

Source: https://www.forbes.com/sites/irisdorbian/2019/12/27/expert-offers-predictions-for-the-hemp-derived-cbd-market-in-2020/#447564bb1391

Tags: , , , , , ,
Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca – Expert Offers Predictions For The Hemp-Derived #CBD Market in 2020 $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca

« Older Entries
Newer Entries »